Professor Kishor Wasan
Art Director, Project Manager, and Web Developer in Saskatoon, SK, Canada
Professor Kishor Wasan has received numerous awards for his contributions to health sciences including the Canadian Society of Pharmaceutical Sciences Leadership award for outstanding contributions to Pharmaceutical Sciences in Canada and is a Fellow of the Canadian Academy of Health Sciences and the American Association of Pharmaceutical Scientists. Professor Wasan has published over 240 peer-reviewed articles and 280 abstracts in the area of lipid-based drug delivery and lipoprotein-drug interactions. Most recently, Professor Kishor Wasan served as the Dean of the College of Pharmacy and Nutrition of the University of Saskatchewan from August 2014 to June 2019. Dr. Kishor Wasan led the research team at the Wasan lab at the University of British Columbia that developed what has become iCo 019, and will initially focus his efforts on the further development of iCo 019 via partnerships and collaborations.
Professor Kishor Wasan was associate dean of research and a tenured professor at the University of British Columbia until 2014. Professor Kishor Wasan has extensive involvement in the development of new research and educational programs and has published over 520 peer review articles and abstracts in top journals. He has demonstrated success in leading research initiatives through his 19 years of independent research at UBC. Wasan completed his undergraduate pharmacy education at the University of Texas at Austin, and a PhD in Cellular and Molecular Pharmacology from the University of Texas Medical Centre in Houston, Texas. Dr. Kishor Wasan has been a practicing pharmacist in both the retail and hospital settings and still maintains a pharmacist license from the State of Texas.
Professor Kishor Wasan is also a Distinguished University Scholar and Canadian Institutes of Health Research/iCo Therapeutics Inc. Research Chair in Drug Delivery for Neglected Global Diseases, as well as a fellow of the Canadian Academy of Health Sciences, the American Association of Pharmaceutical Scientists and the Canadian Society of Pharmaceutical Scientists. He is well-known in the post-secondary field for his strengths in research and education curriculum change.